World's Best Scientists 2026 revealed!
Stephen A. Boorjian

Stephen A. Boorjian

D-Index & Metrics

Medicine

D-Index
104
Citations
37652
World Ranking
7085
National Ranking
3725

Stephen A. Boorjian publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Stephen A. Boorjian sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 945 publications — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Stephen A. Boorjian D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Stephen A. Boorjian sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 104 D-Index — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Stephen A. Boorjian is affiliated with the Mayo Clinic in the United States and has contributed extensively to the field of medicine, particularly focusing on surgery, pulmonary and respiratory medicine, urology, oncology, and molecular biology. Their research covers a wide array of topics primarily related to cancer treatments and urological disorders.

The scientist's main topics of work include:

  • Bladder and Urothelial Cancer Treatments
  • Renal cell carcinoma treatment
  • Urinary and Genital Oncology Studies
  • Prostate Cancer Diagnosis and Treatment
  • Urological Disorders and Treatments
  • Prostate Cancer Treatment and Research
  • Renal and related cancers

Stephen A. Boorjian's frequently published venues include:

  • The Journal of Urology
  • Urologic Oncology Seminars and Original Investigations
  • Journal of Clinical Oncology
  • European Urology
  • Urology

Frequent co-authors who have collaborated with Stephen A. Boorjian in publications are:

  • Bradley C. Leibovich
  • Matthew K. Tollefson
  • R. Houston Thompson
  • John C. Cheville
  • Abhinav Khanna

Among their significant recent papers are:

  • Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology, 2020, Journal of the National Comprehensive Cancer Network
  • Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial, 2020, The Lancet Oncology
  • Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part I: Introduction, Risk Assessment, Staging, and Risk-Based Management, 2022, The Journal of Urology
  • NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022, 2022, Journal of the National Comprehensive Cancer Network
  • Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, Part II: Principles of Active Surveillance, Principles of Surgery, and Follow-Up, 2022, The Journal of Urology

The published works reflect ongoing research interest in bladder and prostate cancer treatment methods, clinical guidelines, and oncological surgery protocols. The number of citations for these publications ranges from over 200 to more than 600, indicating engagement with prominent oncology guidelines and clinical trials.

With a total of 685 publications categorized under medicine and notable contributions in surgery, pulmonary and respiratory medicine, and molecular biology, Stephen A. Boorjian's research spans both clinical and biological aspects of cancer and urological disorders.

Best Publications

  • Epidemiology of Renal Cell Carcinoma.

    Umberto Capitanio;Karim Bensalah;Axel Bex;Stephen A. Boorjian

  • Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline

    Sam S. Chang;Stephen A. Boorjian;Roger Chou;Peter E. Clark

  • Radical Nephrectomy for pT1a Renal Masses May be Associated With Decreased Overall Survival Compared With Partial Nephrectomy

    R. Houston Thompson;Stephen A. Boorjian;Christine M. Lohse;Bradley C. Leibovich

  • Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes

    Jakub Dobruch;Siamak Daneshmand;Margit Fisch;Yair Lotan

  • SUBJECTIVE AND OBJECTIVE ANALYSIS OF THE PREVALENCE OF PEYRONIE’S DISEASE IN A POPULATION OF MEN PRESENTING FOR PROSTATE CANCER SCREENING

    John P. Mulhall;Steven D. Creech;Stephen A. Boorjian;Sam Ghaly

  • Comparative Effectiveness for Survival and Renal Function of Partial and Radical Nephrectomy for Localized Renal Tumors: A Systematic Review and Meta-Analysis

    Simon P. Kim;R. Houston Thompson;Stephen A. Boorjian;Christopher J. Weight

  • Histological Subtype is an Independent Predictor of Outcome for Patients With Renal Cell Carcinoma

    Bradley C. Leibovich;Christine M. Lohse;Paul L. Crispen;Stephen A. Boorjian

  • Survival after complete surgical resection of multiple metastases from renal cell carcinoma

    Angela L. Alt;Stephen A. Boorjian;Christine M. Lohse;Brian A. Costello

  • Comparison of Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses

    R. Houston Thompson;Tom Atwell;Grant Schmit;Christine M. Lohse

  • Long-Term Outcome After Radical Prostatectomy for Patients With Lymph Node Positive Prostate Cancer in the Prostate Specific Antigen Era

    Stephen A. Boorjian;R. Houston Thompson;Sameer Siddiqui;Stephanie Bagniewski

  • Long-Term Risk of Clinical Progression After Biochemical Recurrence Following Radical Prostatectomy: The Impact of Time from Surgery to Recurrence

    Stephen A. Boorjian;R. Houston Thompson;Matthew K. Tollefson;Laureano J. Rangel

  • Comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys reveals predominant role of nonmodifiable factors in determining ultimate renal function.

    Brian R. Lane;Brian R. Lane;Paul Russo;Robert G. Uzzo;Adrian V. Hernandez

  • Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma.

    Paul L. Crispen;Yuri Sheinin;Timothy J. Roth;Christine M. Lohse

  • T-cell coregulatory molecule expression in urothelial cell carcinoma: clinicopathologic correlations and association with survival.

    Stephen A. Boorjian;Yuri Sheinin;Paul L. Crispen;Sara A. Farmer

  • Bladder cancer, version 5.2017: Clinical practice guidelines in oncology

    Philippe E. Spiess;Neeraj Agarwal;Rick Bangs;Stephen A. Boorjian

  • Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Is Safe, Effective, and Efficient Neoadjuvant Treatment for Muscle-Invasive Bladder Cancer: Results of a Multicenter Phase II Study With Molecular Correlates of Response and Toxicity

    Elizabeth R. Plimack;Jean H. Hoffman-Censits;Rosalia Viterbo;Edouard J. Trabulsi

  • Long-Term Survival After Radical Prostatectomy Versus External Beam Radiotherapy for Patients with High-Risk Prostate Cancer

    Stephen A. Boorjian;R. Jeffrey Karnes;Rosalia Viterbo;Laureano J. Rangel

  • Anatomic Features of Enhancing Renal Masses Predict Malignant and High-Grade Pathology: A Preoperative Nomogram Using the RENAL Nephrometry Score

    Alexander Kutikov;Marc C. Smaldone;Brian L. Egleston;Brandon J. Manley

  • Sarcopenia in patients with bladder cancer undergoing radical cystectomy: Impact on cancer‐specific and all‐cause mortality

    Sarah P. Psutka;Alonso Carrasco;Grant D. Schmit;Michael R. Moynagh

  • Mayo Clinic Validation of the D’Amico Risk Group Classification for Predicting Survival Following Radical Prostatectomy

    Stephen A Boorjian;R Jeffrey Karnes;Laureano J Rangel;Eric J Bergstralh

Frequent Co-Authors

John C. Cheville
John C. Cheville Mayo Clinic
Shahrokh F. Shariat
Shahrokh F. Shariat Medical University of Vienna
Michael L. Blute
Michael L. Blute Harvard University
Alberto Briganti
Alberto Briganti Vita-Salute San Raffaele University
Robert G. Uzzo
Robert G. Uzzo Fox Chase Cancer Center
Francesco Montorsi
Francesco Montorsi Vita-Salute San Raffaele University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine doesn't always mean going to medical school. There are multiple related pathways that offer rewarding careers in healthcare. For those interested in the administrative side, options like accredited medical billing and coding schools online with financial aid provide flexible, affordable training for in-demand roles.

If you’re considering nursing, there are now nursing school that don't require teas, making it easier to get started without extensive entrance exams. For those seeking leadership, healthcare administration degrees can open doors to managing hospitals, clinics, or other healthcare facilities.

Already a registered nurse? Explore rn to fnp programs to advance your education and become a Family Nurse Practitioner. Online programs offer the flexibility to study while you work, and many of these alternative degree pathways provide a fast track into some of healthcare’s most vital roles.

Best Scientists Citing Stephen A. Boorjian

Trending Scientists